Oscar Health (NYSE:OSCR) Trading Down 6.4% After Insider Selling

Oscar Health, Inc. (NYSE:OSCR)’s stock price fell 6.4% during trading on Tuesday following insider selling activity. The company traded as low as $29.50 and last traded at $29.2760. 2,169,054 shares traded hands during trading, a decline of 69% from the average session volume of 6,986,087 shares. The stock had previously closed at $31.29.

Specifically, Director Vanessa Wittman sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the completion of the sale, the director owned 112,121 shares in the company, valued at approximately $3,614,781.04. The trade was a 18.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analysts Set New Price Targets

Several brokerages recently commented on OSCR. Robert W. Baird lifted their target price on shares of Oscar Health from $27.00 to $33.00 and gave the stock a “neutral” rating in a research note on Thursday, September 17th. Raymond James Financial increased their price target on shares of Oscar Health from $34.00 to $42.00 and gave the company an “outperform” rating in a research report on Friday, September 18th. Bank of America raised their price target on shares of Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a report on Thursday, September 17th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Finally, Weiss Ratings raised shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $33.90.

Oscar Health Stock Performance

The company’s 50-day moving average price is $30.74 and its 200 day moving average price is $24.44. The stock has a market capitalization of $9.42 billion, a PE ratio of 21.79, a PEG ratio of 0.34 and a beta of 2.37. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter in the previous year, the company earned ($0.89) earnings per share. Oscar Health’s quarterly revenue was up 70.4% on a year-over-year basis. On average, equities research analysts expect that Oscar Health, Inc. will post 1.83 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in OSCR. GAMMA Investing LLC lifted its position in shares of Oscar Health by 32.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after buying an additional 357 shares in the last quarter. IFP Advisors Inc grew its position in shares of Oscar Health by 69.5% during the second quarter. IFP Advisors Inc now owns 2,139 shares of the company’s stock worth $61,000 after purchasing an additional 877 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in shares of Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock worth $34,000 after buying an additional 1,000 shares in the last quarter. Nicholas Wealth LLC. increased its holdings in Oscar Health by 1.3% in the 1st quarter. Nicholas Wealth LLC. now owns 80,268 shares of the company’s stock valued at $921,000 after acquiring an additional 1,017 shares during the last quarter. Finally, Allworth Financial LP raised its holdings in shares of Oscar Health by 124.9% during the 2nd quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock worth $58,000 after acquiring an additional 1,128 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.